Stolk Wilma A, VAN Oortmarssen Gerrit J, Pani S P, DE Vlas Sake J, Subramanian S, DAS P K, Habbema J Dik F
Department of Public Health, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands.
Am J Trop Med Hyg. 2005 Nov;73(5):881-7.
Ivermectin and diethylcarbamazine (DEC) are used in mass treatment programs for the elimination of lymphatic filariasis because of their strong effects on microfilaremia. However, the effects of treatment on adult worms and the degree of individual variation in efficacy are unclear. We analyzed series of microfilaria (Mf) counts from individuals treated with a single dose of 400 microg/kg ivermectin or 6 mg/kg DEC (N = 23 in each group; 1 year follow-up). For each individual, we estimated the microfilaricidal effect and the reduction in overall Mf production (e.g., caused by death or sterilization of worms, or inhibited Mf release from the female worm uterus). Ivermectin on average killed 96% of Mf and reduced Mf production by 82%. DEC killed 57% of Mf and reduced Mf production by 67%, with some individuals responding very poorly. The strong reduction in overall Mf production is good news for control of lymphatic filariasis, but the prospects of elimination will be diminished if part of the population systematically responds poorly to treatment.
伊维菌素和乙胺嗪(DEC)因其对微丝蚴血症有强大作用,被用于大规模治疗项目以消除淋巴丝虫病。然而,治疗对成虫的效果以及疗效的个体差异程度尚不清楚。我们分析了接受单剂量400微克/千克伊维菌素或6毫克/千克DEC治疗的个体(每组N = 23;随访1年)的一系列微丝蚴(Mf)计数。对于每个个体,我们估计了微丝蚴杀灭效果以及总体Mf产生量的减少情况(例如,由蠕虫死亡或绝育,或抑制雌虫子宫释放Mf所致)。伊维菌素平均杀死96%的Mf,并使Mf产生量减少82%。DEC杀死57%的Mf,并使Mf产生量减少67%,一些个体反应很差。总体Mf产生量的大幅减少对淋巴丝虫病的控制来说是个好消息,但如果部分人群对治疗系统性反应不佳,消除淋巴丝虫病的前景将会受到影响。